Singapore to close Johns Hopkins unit

1 October 2006

The government of Singapore is to close the Johns Hopkins University's biomedical center stating that its program has failed to yield results, according to Andre Wan, director of the state Biomedical Research Council, who added that although the government had spent more than $50.0 million in eight years, the Johns Hopkins facility had failed to attract top-notch scientists.

The Council stated the Johns Hopkins program will officially end on May 31, 2007. About 60 employees have received their termination notices and have been told to start winding down their projects. The Johns Hopkins Singapore International Medical Center, a separate entity, will not be affected by the changes.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight